Literature DB >> 19208881

Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease.

Mandira Varma-Basil1, Shailendra K D Dwivedi1, Krishna Kumar1, Rakesh Pathak1, Ritika Rastogi1, S S Thukral1, Malini Shariff1, V K Vijayan2, Sunil K Chhabra2, Rama Chaudhary3.   

Abstract

Eighty per cent of the cases of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) have an infective aetiology, atypical bacteria including Mycoplasma pneumoniae accounting for 5-10 % of these. However, the importance of association of M. pneumoniae with episodes of AECOPD still remains doubtful. The present study was therefore undertaken to delineate the extent of involvement of M. pneumoniae in patients with AECOPD at a referral hospital in Delhi, India. Sputum samples and throat swabs from a total of 100 AECOPD patients attending the Clinical Research Center of Vallabhbhai Patel Chest Institute, Delhi, were collected during a 2-year period (January 2004-June 2006). The samples were investigated for the presence of aerobic bacterial pathogens and M. pneumoniae. Diagnosis of infection with M. pneumoniae was based on culture, serology, direct detection of M. pneumoniae specific antigen and PCR. Bacterial aetiology could be established in 16 of the 100 samples studied. Pseudomonas spp. were recovered from eight cases, Streptococcus pneumoniae from four and Klebsiella spp. from two cases. Acinetobacter sp. and Moraxella catarrhalis were isolated from one case each. Serological evidence of M. pneumoniae infection and/or detection of M. pneumoniae specific antigen were seen in 16 % of the cases. One case with definite evidence of M. pneumoniae infection also had coinfection with Pseudomonas spp. However, no direct evidence of M. pneumoniae infection was found in our study population as defined by culture isolation or PCR. In conclusion, although the serological prevalence of M. pneumoniae infection in our study population was significantly higher than in the control group, there was no direct evidence of it playing a role in AECOPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208881     DOI: 10.1099/jmm.0.003335-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Rapid mycoplasma culture for the early diagnosis of Mycoplasma pneumoniae infection.

Authors:  Ling-di Ma; Baojin Chen; Yanfen Dong; Jing Fan; Lei Xia; Shi-zhong Wang; Qian Liu; Lijia Jiang
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  In vivo function of airway epithelial TLR2 in host defense against bacterial infection.

Authors:  Qun Wu; Di Jiang; Maisha N Minor; Richard J Martin; Hong Wei Chu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

3.  Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor.

Authors:  Jennifer L Booth; Todd M Umstead; Sanmei Hu; Kevin F Dybvig; Timothy K Cooper; Ronald P Wilson; Zissis C Chroneos
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

Review 4.  PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis.

Authors:  Lei Zhang; Zhi-Yong Zong; Yan-Bin Liu; Hui Ye; Xiao-Ju Lv
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

5.  Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.

Authors:  Shigeo Muro; Yasuharu Tabara; Hisako Matsumoto; Kazuya Setoh; Takahisa Kawaguchi; Meiko Takahashi; Isao Ito; Yutaka Ito; Kimihiko Murase; Chikashi Terao; Shinji Kosugi; Ryo Yamada; Akihiro Sekine; Takeo Nakayama; Kazuo Chin; Michiaki Mishima; Fumihiko Matsuda
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Use of serology and polymerase chain reaction to detect atypical respiratory pathogens during acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Chi Young Jung; Yeoung Hun Choe; Sang Yeub Lee; Woo Jin Kim; Jong Deog Lee; Seung Won Ra; Eu Gene Choi; Jae Seung Lee; Myung Jae Park; Ju Ock Na
Journal:  Korean J Intern Med       Date:  2018-06-25       Impact factor: 2.884

7.  Inhaled corticosteroid influence toll like receptor 2 expression in induced sputum from patients with COPD.

Authors:  Haixing Zhu; Yuheng Shi; Wei Tang; Guocao Shi; Huanyin Wan
Journal:  Transl Respir Med       Date:  2013-03-19

8.  Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.

Authors:  Hanaa Ahmed Shafiek; Nashwa Hassan Abd-Elwahab; Manal Mohammad Baddour; Mohamed Mabrouk El-Hoffy; Akram Abd-Elmoneim Degady; Yehia Mohamed Khalil
Journal:  ISRN Microbiol       Date:  2012-06-21

Review 9.  Biological functions of IL-17-producing cells in mycoplasma respiratory infection.

Authors:  Ying Luo; Cheng Li; Zhou Zhou; Zhande Gong; Cuiming Zhu; Aihua Lei
Journal:  Immunology       Date:  2021-05-19       Impact factor: 7.215

10.  Prevalence of Mycoplasma Pneumoniae Infection in Patients with COPD Exacerbation; a Letter to the Editor.

Authors:  Ali Reza Amiri; Kiarash Ghazvini; Hamid Zamani Moghadam
Journal:  Emerg (Tehran)       Date:  2018-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.